The nature of the inhibitory action of mammalian prolactin on the development of bullfrog tadpoles was investigated. Tadpoles injected ip with 20 jug of thyroxine (T 4 ) and 2 or 4 mg of ovine prolactin (NIH-P-S-7) underwent metamorphic changes in parallel with T 4 -injected controls. By contrast, tadpoles injected with 4 IU of bovine thyrotropic hormone (TSH) and either 4.0 or 0.4 mg of prolactin entered into developmental stasis after showing early signs of metamorphic climax, while TSH-injected controls completed the various metamorphic steps, including tail resorption. Histological examination of the thyroids of animals treated with both TSH and prolactin revealed an extremely high degree of hypertrophy and hyperplasia, with more pronounced depletion of the colloid than in TSH-injected controls. It is concluded that in these experiments prolactin acts at the level of the thyroid and that it has goitrogenic properties. (Endocrinology 8 1 : 748, 1967) P ROLACTIN appears to possess a great diversity of actions in different vertebrates aside from its well-known effects in mammals. For example, it elicits "waterdrive," or second metamorphosis, in the red eft stage of the common newt (1, 2). Another role concerns osmoregulation in fish (3). Excess growth in tadpoles carrying ectopic pituitary transplants was reported by Etkin and Lehrer (4), who postulated that this was the result of an increased rate of prolactin secretion by the ectopic pituitaries which are freed from the normally existing hypothalamic inhibition of prolactin release. Other investigations demonstrated that mammalian prolactin has a marked growth-promoting effect in tadpoles (5-8). Olivereau (9) reported a thyroid-stimulating effect of prolactin in eels and concluded that this hormone acts as a thyrotropin-releasing factor in these fish. More recently, it was found (10) that mammalian prolactin inhibits metamor-